The present disclosure relates to amorphous and crystalline forms of (R)-N-(4-chlorophenyl)-2-((1S,4S)-4-(6-fluoro-quinolin-4-yl) cyclohexyl)propanamide and its salts and hydrates, processes for their production, pharmaceutical compositions comprising them, and methods of treatment using them.
本公开涉及无定形和结晶形式的(R)-N-(4-
氯苯基)-2-((1S,4S)-4-(6-
氟-
喹啉-4-基)环己基)丙酰胺及其盐类和
水合物、其生产工艺、包含它们的药物组合物以及使用它们的治疗方法。